Anika Therapeutics (ANIK) EPS (Basic) (QoQ) (2010 - 2025)
Anika Therapeutics (ANIK) EPS (Basic) (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -279.36% |
| Sep 30, 2025 | 24.49% |
| Jun 30, 2025 | 173.64% |
| Mar 31, 2025 | 95.14% |
| Dec 31, 2024 | 30.75% |
| Sep 30, 2024 | -1,249.94% |
| Jun 30, 2024 | 194.98% |
| Mar 31, 2024 | -115.76% |
| Dec 31, 2023 | 347.14% |
| Sep 30, 2023 | -139.43% |
| Jun 30, 2023 | 73.49% |
| Mar 31, 2023 | -201.78% |
| Dec 31, 2022 | 342.65% |
| Sep 30, 2022 | -45.91% |
| Jun 30, 2022 | 2.83% |
| Mar 31, 2022 | 10.48% |
| Dec 31, 2021 | -687.01% |
| Sep 30, 2021 | -91.57% |
| Jun 30, 2021 | 129.29% |
| Mar 31, 2021 | 117.93% |